Unable to locate Global Block : 19750
MD Anderson Cancer Center | September 24, 2026

Brain Metastases in Melanoma

When melanoma spreads to the brain, patients and their families can face new questions, concerns, and treatment decisions. Understanding what brain metastases are, how they are treated, and what to expect can help patients and caregivers feel better informed as they navigate care.

Join AIM at Melanoma and experts from The University of Texas MD Anderson Cancer Center for a live educational program focused on brain metastases in melanoma. Medical oncologist Isabella Glitza, MD, and radiation oncologist Thomas Beckham, MD, will discuss how brain metastases are diagnosed, current treatment approaches—including immunotherapy, targeted therapy, surgery, and focused radiation—and clinical trials exploring new treatment strategies.

The program will also address the day-to-day realities of living with brain metastases, including symptoms, treatment side effects, changes in thinking or memory, rehabilitation, emotional support, caregiver needs, and maintaining quality of life.

The evening will conclude with a live Q&A, giving patients and caregivers an opportunity to hear directly from melanoma specialists and have their questions addressed.

Date: September 24, 2026
Time: 6:30 pm ET, 5:30 pm CT, 4:30 pm MT, 3:30 pm PT
Location: This symposium is held virtually. Register below to attend virtually.

Presenters & Topics

Isabella Glitza, MD
Medical Oncologist
Professor, Melanoma Medical Oncology
The University of Texas MD Anderson Cancer Center – Houston, Texas

Thomas Beckham, MD
Radiation Oncologist
Assistant Professor, Radiation Oncology
The University of Texas MD Anderson Cancer Center – Houston, TX

5:30 PM CT

Welcome

5:35 PM CT

Brain Metastases 101 – Understanding the Diagnosis
o What is a brain metastasis?
o How common is it in melanoma?
o What symptoms should patients watch for?
o How are brain metastases found?

5:50 PM CT

Overview of Available Treatment Options
o Immunotherapy: helping the immune system recognize and attack cancer
o Targeted therapy: medicines designed to attack specific changes
in melanoma cells
o Surgery: removing a brain metastasis when appropriate
o Focused radiation: precisely treating tumors in the brain

6:10 PM CT

Living With Brain Metastases 
o Headaches, seizures, weakness, and other symptoms
o Fatigue and changes in thinking or memory
o Managing treatment side effects
o The role of rehabilitation
o Emotional and psychological support
o Supporting caregivers
o Maintaining quality of life during treatment

6:30 PM CT

Current Clinical Trials

6:40 PM CT

Patient Resources
Ann Garst Taylor
Director of Community Engagement
AIM at Melanoma

6:45 PM CT

Live Q&A


REGISTRATION